Role of interleukin-1β in the development of retinopathy in rats: Effect of antioxidants

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 4161-4166

  Kowluru, Renu A ^a   Odenbach, Sarah ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; 8-HYDROXY-2'-DEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE; INTERLEUKIN 1; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RETINA CAPILLARY; ANIMAL; CAPILLARY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CAPILLARIES; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; IN SITU NICK-END LABELING; INTERLEUKIN-1; MALE; NF-KAPPA B; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINAL VESSELS;

EID: 6944233576     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0633     Document Type: Article

References (47)

1. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50:1938-1942.
2. Xia P, Inoguchi T, Kern TS, et al. Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes. 1994;43:1122-1129.
3. Stitt AW, Li YM, Gardiner TA, et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523-531.
4. Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29:354-362.
5. Lutty GA, McLeod DS, Merges C, et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996;114:971-977.
6. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883-2890.
7. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000;41:3972-3978.
8. Romeo G, Liu WH, Asnaghi V, et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51:2241-2248.
9. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci. 2003;44:5327-5334.
10. Kowluru RA, Koppolu P. Diabetes-induced activation of Caspase-3 in retina: effect of antioxidant therapy. Free Radic Res. 2002;36:993-999.
11. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169-1180.
12. Abu el Asrar AM, Maimone D, Morse PH, et al. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 1992;114:731-736.
13. Yuuki T, Kanda T, Kimura Y, et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications. 2001;15:257-259.
14. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Res. 1999;39:3817-3823.
15. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203-1206.
16. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes. 2001;50:1432-1439.
17. Joussen AM, Murata T, Tsujikawa A, et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158:147-152.
18. Joussen AM, Huang S, Poulaki V, et al. In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci. 2001;42:3047-3057.
19. Li W, Yanoff M, Jian B, He Z. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol. 1999;45:59-66.
20. Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol. 2004;88:1343-1347.
21. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes. 2001;50:1636-1642.
22. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-412.
23. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42:1075-1081.
24. Vassilakopoulos T, Karatza M-H, Katsaounou P, et al. Antioxidants attenuate the plasma cytokine response to exercise in humans. J Appl Physiol. 2003;94:1025-1032.
25. Chang CK, LoCicero J. Overexpressed nuclear factor κB correlates with enhanced expression of interleukin-1β and inducible nitric oxide synthase in aged murine lungs to endotoxic stress. Ann Thorac Surg. 2004;77:1222-1227.
26. Huang X, Powell J, Mponey LA, et al. Importance of complete DNA digestion in minimizing variability of 8-oxo-dG analyses. Free Radic Biol Med. 2001;31:1341-1351.
27. Kowluru RA, Abbas SN, Odenbach S. Effect of re-institution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabetes Complications. 2004;18:282-288.
28. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes. 2004;53:775-783.
29. Kowluru RA, Odenbach S. Effect of long-term administration of α-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. In press.
30. Amano K, Okigaki M, Adachi Y, et al. Mechanism for IL-1β-mediated neovascularization unmasked by IL-1β knock-out mice. J Mol Cell Cardiology. 2004;36:469-480.
31. Castigli E, Arcuri C, Giovagnoli L, et al. Interleukin-1beta induces apoptosis in GL15 glioblastoma-derived human cell line. Am J Physiol. 2000;279:C2043-C2049.
32. Kern TS, Engerman RL. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curt Eye Res. 1994;13:863-867.
33. Boutin H, Kimber I, Rothwell NJ, Pinteaux E. The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain? Mol Neurobiol. 2003;27:239-248.
34. Ohtaki H, Takaki A, Yin L, et al. Suppression of oxidative stress after transient focal ischemia in interleukir-1 knock out mice. Acta Neurochir Suppl. 2003;86:191-194.
35. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, et al. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab. 1996;81:3197-3202.
36. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
37. Baeuerle PA. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072:63-80.
38. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000;28:1405-1420
39. Yanagihara Y, Basaki Y, Kajiwara K, Ikizawa K. A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB. J Allergy Clin Immunol. 1997;100:S33-S38.
40. Tian B, Liu J, Bitterman PB, Bache RJ. Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis. Am J Physiol. 2002;283:H1958-H1967.
41. Ferdinandy P, Danial H, Ambrus I, et al. Peroxynitrite is a major contributor to cytokine-induced myocarxial contractile failure. Circ Res. 2000;87:241-247.
42. Kowluru RA. Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress n diabetic rats. Diabetes. 2003;52:818-823.
43. Du Y, Smith MA, Miller CM, Kern TS. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem. 2002;80:771-779.
44. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. Effect of cyclosporin-A on the blood-retinal barrier permiability in streptozotocin-induced diabetic retinopathy. Mediators Inflamm. 2000;9:243-248.
45. Gonzalez R, Sanchez de Medina F, Galvez J, et al. Dietary vitamin E supplementation protects the rat large intestine from experimental inflammation. Int J Vitam Nutr Res. 2001;71:243-250.
46. Takii T, Kawashima S, Chiba T, et al. Multiple mechanisms involved in the inhibition of proinflammator cytokine production from human monocytes by N-(p-coumaroyl)serotonin and its derivatives. Int Immunopharmacol. 2003;3:273-277.
47. Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res. 2002;36:1331-1336.